BioGend Therapeutics Co., Ltd. (TPEX:6733)

Taiwan · Delayed Price · Currency is TWD

26.20

-2.70 (-9.34%)

Jul 30, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	222.34M	167.65M	109.91M	31.45M	9.27M
Total	222.34M	167.65M	109.91M	31.45M	9.27M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Hong Kong and Chinese Mainland	2.22M	1.14M	-	-	-
Taiwan	218.69M	161.41M	73.54M	31.14M	8.99M
Other	-	2.50M	101.00K	300.00K	-
Malaysia	1.43M	1.90M	-	-	-
Japan	-	696.00K	24.88M	10.00K	-
China	-	-	11.39M	-	-
America	-	-	-	-	276.00K
Total	222.34M	167.65M	109.91M	31.45M	9.27M